Intrinsic Value of S&P & Nasdaq Contact Us

Danaher Corporation DHR NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
67/100
4/7 Pass
SharesGrow Intrinsic Value
$221.74
+11.6%
Analyst Price Target
$253.75
+27.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Danaher Corporation (DHR) trades at a trailing P/E of 38.0, forward P/E of 23.6. Trailing earnings yield is 2.63%, forward earnings yield 4.23%. PEG 0.35 (Peter Lynch undervalued ≤1.0). Graham Number is $92.41.

Criteria proven by this page:

  • VALUE (32/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 23.6 (down from trailing 38.0) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.35 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 2.63% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 4.23% as earnings recover.
  • Analyst consensus target $253.75 (+27.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 67/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
67/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
Proven by this page
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
86/100
→ Income
GROWTH
15/100
→ Income
~
INCOME
55/100
→ Income

Valuation Snapshot — DHR

Valuation Multiples
P/E (TTM)38.0
Forward P/E23.6
PEG Ratio0.35
Forward PEG0.35
P/B Ratio2.62
P/S Ratio5.59
EV/EBITDA21.8
Per Share Data
EPS (TTM)$5.11
Forward EPS (Est.)$8.41
Book Value / Share$74.27
Revenue / Share$34.73
FCF / Share$7.44
Yields & Fair Value
Earnings Yield2.63%
Forward Earnings Yield4.23%
Dividend Yield0.70%
Graham Number$92.41
SharesGrow IV$221.74 (+11.6%)
Analyst Target$253.75 (+27.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 18.7 -0.80 2.07 2.83 0.84%
2017 23.0 -7.71 2.17 3.12 0.66%
2018 24.2 4.32 2.27 3.76 0.68%
2019 38.0 -4.79 3.21 5.43 0.54%
2020 38.1 0.89 3.50 6.24 0.44%
2021 32.4 0.42 4.61 7.08 0.36%
2022 23.7 2.01 3.41 6.40 0.48%
2023 35.8 -1.04 3.19 7.13 0.48%
2024 43.0 -2.50 3.39 7.03 0.46%
2025 44.8 -9.18 3.08 6.59 0.54%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $3.65 $16.88B $2.55B 15.1%
2017 $3.53 $18.33B $2.49B 13.6%
2018 $3.73 $19.89B $2.65B 13.3%
2019 $3.43 $17.91B $3.01B 16.8%
2020 $4.89 $22.28B $3.65B 16.4%
2021 $8.61 $29.45B $6.43B 21.8%
2022 $9.64 $31.47B $7.21B 22.9%
2023 $6.38 $23.89B $4.76B 19.9%
2024 $5.29 $23.88B $3.9B 16.3%
2025 $5.04 $24.57B $3.61B 14.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $8.41 $8.36 – $8.52 $25.62B $25.28B – $26.21B 14
2027 $9.11 $9.00 – $9.24 $27.13B $26.69B – $29.18B 14
2028 $10.01 $8.82 – $11.73 $28.84B $28.8B – $28.88B 4
2029 $10.88 $10.71 – $11.34 $30.49B $30.13B – $31.48B 2
2030 $11.81 $11.63 – $12.31 $31.95B $31.56B – $32.99B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message